首页> 外文期刊>Annals of the New York Academy of Sciences >Aortic Aneurysm, Thoracoabdominal Aneurysm, Juxtarenal Aneurysm, Fenestrated Endografts, Branched Endografts, and Endovascular Aneurysm Repair
【24h】

Aortic Aneurysm, Thoracoabdominal Aneurysm, Juxtarenal Aneurysm, Fenestrated Endografts, Branched Endografts, and Endovascular Aneurysm Repair

机译:主动脉瘤,胸腹主动脉瘤,近侧肾动脉瘤,有孔内膜移植,分支内膜移植和血管内动脉瘤修复

获取原文
获取原文并翻译 | 示例
       

摘要

The development of endovascular devices to treat aneurysms that abut or involve the visceral vessels has occurred in an effort to reduce the significant procedural morbidity and mortality associated with conventional repair. To accomplish this, three systems have been trialed. The first technique was developed to treat juxtarenal aneurysms and involves the placement of customized fenestrations strategically placed within the fabric of the graft. These are aligned with the ostia of the visceral vessels incorporated by the repair and supplemented by the placement of a balloon expandable stent. In a similar fashion, aneurysms that involve the visceral vessels can be treated with a fenestrated graft where the fenestration is reinforced with a nitinol ring. This is then mated with a balloon-expandable stentgraft, allowing the devices to seal at the level of the nitinol ring. An alternative means of incorporating the visceral vessels is to use directional branches where one or more additional limbs (typically 8 mm) are anastomosed to the aortic graft, through which access into the visceral vessel is attained. Mating stentgrafts for the later design can be of a self-expanding or balloon expandable nature. The experience with fenestrated devices is mature and associated with a low perioperative mortality (< 2%) without many long-term complications. The treatment of thoracoabdominal aneurysms with branches has provided us with optimism regarding the technique, but results are only short term in nature. Further device development is ongoing and dissemination of this technology is now occurring in Europe, Australia and Canada.
机译:为了减少与常规修复有关的显着的手术发病率和死亡率,已经开发出了用于治疗邻接或累及内脏血管的动脉瘤的血管内装置。为此,已经试用了三个系统。开发了第一种技术来治疗近侧肾动脉瘤,并涉及将定制窗孔的位置策略性地放置在移植物的织物内。这些与通过修复结合的内脏血管的口对齐,并通过放置球囊可扩张支架进行补充。以类似的方式,涉及内脏血管的动脉瘤可用开窗的移植物治疗,开窗处用镍钛合金环加强。然后将其与球囊可扩张的支架移植物配对,以使装置在镍钛合金环的水平处密封。合并内脏血管的另一种方法是使用定向分支,其中将一个或多个其他肢体(通常为8 mm)与主动脉吻合,通过该分支可以进入内脏血管。用于以后的设计的对接支架移植物可以具有自扩张或球囊扩张的性质。开窗器的经验很成熟,围手术期死亡率低(<2%),无许多长期并发症。分支治疗胸腹动脉瘤使我们对该技术持乐观态度,但结果仅是短期的。正在进行进一步的设备开发,并且正在欧洲,澳大利亚和加拿大推广这种技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号